Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 janv. 2018 11h30 HE | Source: Emerald Health Pharmaceuticals Inc.

Emerald Health Pharmaceuticals to Present at the Biotech Showcase™ Annual Conference

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that it will present at Biotech...
20 oct. 2017 07h00 HE | Source: Emerald Health Pharmaceuticals Inc.

Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic Scleroderma

SAN DIEGO, Oct. 20, 2017 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug...
20 sept. 2017 07h00 HE | Source: Emerald Health Pharmaceuticals Inc.

Emerald Health Pharmaceuticals’ Scientific Team Leads Cannabinoid Research Showing Potential to Impact Neurodegenerative Diseases

SAN DIEGO, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a development-stage company focused on treating life-threatening diseases through cannabinoid science, is...
14 sept. 2017 09h00 HE | Source: Emerald Health Pharmaceuticals Inc.

Emerald Health Pharmaceuticals to Treat Life-Threatening Diseases with Novel Synthetic Cannabinoid-Derived Molecules

SAN DIEGO, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP) today announced its mission to discover, develop and commercialize novel synthetic cannabinoid-derivative drug...